Company intelligence / Profile preview

Government Pharmaceutical Organization

Bangkok, Bangkok, Thailand

Ownership: Private
Employees: ~2100
Development stage: Commercial

Overview

The GPO manufactures various pharmaceutical products including vaccines such as JE(MB) vaccine, antiserum of tetanus, and antisnake venoms. They have also developed H1N1 2009 PLAIV which completed phase II clinical trials[1].

Therapeutic areas: Infectious Diseases
Modalities: VaccinesAntiseraPharmaceutical productsHerbal products
Industry: Biotech

Drug pipeline

6 assets

Tri Fluvac

5 more assets in the full pipeline.

Request access →

Partnerships

WHO (World Health Organization)

Beyond the preview

Go deeper on Government Pharmaceutical Organization.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Government Pharmaceutical Organization.

Explore the full profile